Daniel Reisel

ORCID: 0000-0001-9018-4621 · 5 papers in corpus · active 2016-2022

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
2022
Genome medicine ·doi:10.1186/s13073-022-01063-5

BackgroundBreast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising pr…

article 2022
BMJ case reports ·doi:10.1136/bcr-2021-247757

Transabdominal cerclage (TAC) is a recognised treatment for recurrent spontaneous late miscarriage or preterm birth due to cervical weakness. This can be performed via an open procedure before and during pregnancy, or a laparoscopic techniq…

2022
Nature communications ·doi:10.1038/s41467-021-26615-y

The vast majority of epithelial ovarian cancer arises from tissues that are embryologically derived from the Müllerian Duct. Here, we demonstrate that a DNA methylation signature in easy-to-access Müllerian Duct-derived cervical cells from …

other 2017
Genome medicine ·doi:10.1186/s13073-017-0500-7

BACKGROUND: Despite a myriad of attempts in the last three decades to diagnose ovarian cancer (OC) earlier, this clinical aim still remains a significant challenge. Aberrant methylation patterns of linked CpGs analyzed in DNA fragments shed…

2016
Nature communications ·doi:10.1038/ncomms11620

The exact timing and contribution of epigenetic reprogramming to carcinogenesis are unclear. Women harbouring BRCA1/2 mutations demonstrate a 30-40-fold increased risk of high-grade serous extra-uterine Müllerian cancers (HGSEMC), otherwise…